Overview
Dr. Jimenez Jimenez, who joined the Division of Transplantation and Cell Therapy in 2016, leads Sylvesters Mismatched Allogeneic Transplant Program. His clinical and research work is dedicated to improving access to Hematopoietic Cell Transplantation (HCT) for ethnically diverse patients who lack suitable donors. A national leader in mismatched HCT, Dr. Jimenez chairs multiple trials and played a key role in establishing Sylvesters program. He also focuses on strategies to reduce relapse risk in patients with acute leukemias and myeloid neoplasms post-transplant.
Dr. Jimenez is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Graft.
He is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 2 clinical trials. Dr. Jimenez is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Dr. Lekakis is a Professor of Medicine who joined the University of Miami in 2010 and became an attending physician for Hemotology/Oncology and Blood and Marrow Transplantation in 2012. He has since started the CAR-T trials, performed the first CAR-T for solid tumors, and transplanted adult sickle cell disease patients. Dr. Lekakis is a member of the USA CAR-T Consortium and several CIBMTR committees including CAR-T, Lymphoma, Leukemia, and GVHD. His main interests are CAR-T and GVHD. Dr. Lekakis is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant. Dr. Lekakis is currently accepting new patients.
Rafat Abonour is a Hematologist Oncology provider practicing medicine in Miami, Florida. Dr. Abonour is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Transplant. Dr. Abonour is currently accepting new patients.
Egil And Pauline Braathen Center/Maroone Cancer Center
David Baran is a Transplant Surgeon practicing medicine in Weston, Florida. Dr. Baran is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Heart Failure, Heart Attack, Heart Transplant, and Patent Foramen Ovale Repair. Dr. Baran is board certified in American Board Of Internal Medicine, 2010.
Frequently Asked Questions about Dr. Antonio M. Jimenez
How do I make an appointment with Dr. Antonio M. Jimenez?
You can book an appointment with Dr. Antonio M. Jimenez by calling their office at 305-243-5302. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Antonio M. Jimenez a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Antonio M. Jimenez is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Antonio M. Jimenez specialize in?
While Dr. Antonio M. Jimenez is a Transplant Surgery, they have specific expertise in Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Antonio M. Jimenez participate in research or clinical trials?
Yes. Dr. Antonio M. Jimenez has published 64 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Antonio M. Jimenez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Antonio M. Jimenez accept my insurance?
Dr. Antonio M. Jimenez accepts most major insurance plans, including Aetna and AvMed. We recommend calling the office directly at 305-243-5302 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Jimenez isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Bone Marrow TransplantDr. Jimenez isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Jimenez isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Graft Versus Host Disease (cGvHD)
- Graft Versus Host Disease (GvHD)Dr. Jimenez isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaDr. Jimenez isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Jimenez isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaDr. Jimenez isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Jimenez isExperienced. Learn about Agranulocytosis.
- Angioimmunoblastic T-cell LymphomaDr. Jimenez isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Jimenez isExperienced. Learn about Aplastic Anemia.
- Bone GraftDr. Jimenez isExperienced. Learn about Bone Graft.